Alertix Veterinary Diagnostics develops and markets a new unique assay for diagnosing cell growth for veterinary use. The assay is also very useful for monitoring and follow-up of cancer treatment and furthermore for screening companion animals over a certain age.
Did you know that our companion animals are afflicted by cancer as often as humans? Dogs and cats share not only our living environment but also our lifestyle. Because of this they are exposed to the same risk factors for cancer. Veterinary care is getting better and better at treating cancer in companion animals. But the crucial factor of success is that the disease is detected in time.Read more about cancer in companion animals
Today, Alertix received the innovation award SKAPA at a ceremony at the governor’s residence by the Governor Thomas Carlzon. Besides of the money-based award, Alertix will also be a participant in the national innovation award in November at Älvsjö, Sweden, when the Swedish master of innovation will be announced.Read more
Alertix® is now registered as trademark both in Europe and internationallyRead more
At an international conference in Uppsala Sweden, Uppsala Health Summit 14-15 June 2018, professor Henrik Rönnberg, SLU Uppsala, co-organized a workshop named Towards Useful Cancer Biomarkers to Improve Cancer Care.Read more